✦ LIBER ✦

Safety and regulatory requirements and challenge for CNS drug development

✍ Scribed by Gad, Shayne C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enantiomeric drug development: Issues, c

✍ Nuggehally R. Srinivas; Rashmi H. Barbhaiya; Kamal K. Midha 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Challenging the regulatory requirement f

✍ Sally Robinson; Vicente Nogués; Deborah Ockert; Peter Stei; David Dreher; Kev So 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Challenging the regulatory requirement f

✍ Sally Robinson; Deborah Ockert; Petet Stei; David Dreher; Kev Somers; Elizabeth 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Promise of new translational safety biom

✍ Sistare, Frank D; DeGeorge, Joseph J 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 514 KB

Principles of CNS Drug Development || Pr

✍ Kelly, John 📂 Article 📅 2010 🏛 John Wiley & Sons, Ltd ⚖ 313 KB 👁 2 views

CNS drug development in Europe — Past pr

✍ Nutt, David J.; Attridge, Jim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 495 KB